Mutual of America Capital Management LLC Sells 1,051 Shares of Amedisys, Inc. (NASDAQ:AMED)

Mutual of America Capital Management LLC decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 5.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 20,166 shares of the health services provider’s stock after selling 1,051 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Amedisys were worth $1,917,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. SG Americas Securities LLC raised its holdings in Amedisys by 181.1% during the 4th quarter. SG Americas Securities LLC now owns 63,953 shares of the health services provider’s stock worth $6,079,000 after purchasing an additional 41,206 shares during the last quarter. Bank of Nova Scotia bought a new position in Amedisys during the 3rd quarter worth approximately $26,671,000. Hsbc Holdings PLC raised its holdings in Amedisys by 184.9% during the 3rd quarter. Hsbc Holdings PLC now owns 110,479 shares of the health services provider’s stock worth $10,327,000 after purchasing an additional 71,705 shares during the last quarter. Clear Street Markets LLC bought a new stake in shares of Amedisys in the 3rd quarter valued at $1,252,000. Finally, UBS Group AG increased its stake in shares of Amedisys by 336.5% in the 3rd quarter. UBS Group AG now owns 42,301 shares of the health services provider’s stock valued at $3,951,000 after acquiring an additional 32,610 shares in the last quarter. Institutional investors own 94.36% of the company’s stock.

Amedisys Stock Performance

NASDAQ AMED opened at $90.40 on Friday. The company has a fifty day simple moving average of $92.77 and a 200 day simple moving average of $93.40. Amedisys, Inc. has a 12-month low of $73.10 and a 12-month high of $96.44. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.32. The company has a market cap of $2.95 billion, a P/E ratio of -291.60, a PEG ratio of 4.27 and a beta of 0.86.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings results on Wednesday, February 21st. The health services provider reported $0.94 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.04 by ($0.10). Amedisys had a negative net margin of 0.44% and a positive return on equity of 12.76%. The business had revenue of $570.79 million during the quarter, compared to analyst estimates of $566.85 million. During the same period in the previous year, the business posted $1.16 EPS. The business’s revenue for the quarter was up 1.6% compared to the same quarter last year. Sell-side analysts predict that Amedisys, Inc. will post 4.54 earnings per share for the current fiscal year.

Analyst Ratings Changes

AMED has been the subject of several research analyst reports. StockNews.com initiated coverage on shares of Amedisys in a research note on Monday, April 8th. They issued a “buy” rating for the company. Raymond James reiterated a “market perform” rating on shares of Amedisys in a research note on Tuesday, March 26th. Finally, Royal Bank of Canada lifted their price objective on shares of Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, March 25th. Seven analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, Amedisys currently has a consensus rating of “Hold” and an average target price of $97.50.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.